/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced MiniMed as the name for the planned New Diabetes Company following the

/ -- 全球医疗技术领导者美敦力公司（纽约证券交易所代码：MDT）今天宣布，计划中的新糖尿病公司将命名为MiniMed。

intended separation

预期分离

. The name honors the company's roots, reflecting its original name prior to its acquisition by Medtronic in 2001, and a deep 40-year history of being at the forefront of transforming diabetes care around the world.

。该名称体现了公司根源，反映了其在2001年被美敦力收购之前的原始名称，以及其在世界范围内推动糖尿病护理变革的40年深厚历史。

'Our journey began in 1983, when visionary entrepreneur

“我们的旅程始于1983年，当时富有远见的企业家

Alfred E. Mann

阿尔弗雷德·E·曼恩

founded MiniMed and revolutionized diabetes care with many first-of-its-kind innovations that pushed the boundaries of care and helped simplify life with diabetes for countless people around the world,' said Que Dallara, current EVP and President of Medtronic Diabetes and Chief Executive Officer designate of MiniMed.

“创立了MiniMed，并通过许多首创的创新技术彻底改变了糖尿病护理，突破了护理的界限，帮助全世界无数糖尿病患者简化了生活。”现任美敦力糖尿病业务执行副总裁兼总裁、MiniMed首席执行官指定人选的Que Dallara表示。

'We're thrilled to honor this rich 40-year legacy with a name that carries deep meaning and trust. As we step forward into this new and exciting chapter, we'll focus relentlessly on fulfilling our Mission to make diabetes more predictable so everyone can embrace life to the fullest.'.

“我们非常兴奋能够以一个承载深远意义和信任的名字来纪念这丰富的40年传承。在我们迈入这一全新且激动人心的篇章时，我们将毫不动摇地专注于实现我们的使命——让糖尿病变得更可预测，以便每个人都能充分享受生活。”

Managing diabetes can feel draining and exhausting due to the constant mental and physical demands to keep glucose levels in a healthy range. Every meal and activity requires careful calculation — counting carbs, adjusting insulin, and monitoring levels to prevent dangerous low and high blood sugars that can result in both short- and long-term complications.

管理糖尿病会让人感到疲惫不堪，因为需要持续付出心力和体力，以保持血糖水平在健康范围内。每一餐和每项活动都需要仔细计算——计算碳水化合物、调整胰岛素并监测血糖水平，以防止可能导致短期和长期并发症的危险的低血糖和高血糖。

The company's Mission is inspired by the desire to introduce more stability and predictability with technology that helps push diabetes management into the background..

公司的使命是受到通过技术引入更多稳定性和可预测性的愿望的启发，这项技术有助于将糖尿病管理置于后台。

For many employees, the Mission hits close to home—over 70% of those surveyed have a personal connection to diabetes. That includes Key Payton, who has been with the company for over a decade and was diagnosed with type 1 diabetes in 1960. 'When I was just three years old, doctors told my parents I likely wouldn't live past 10.

对许多员工而言，这一使命意义重大——超过70%的受访者与糖尿病有着个人联系。这其中就包括已在公司工作十余年的凯·佩顿，他于1960年被诊断出患有1型糖尿病。“在我只有三岁的时候，医生告诉我父母，我可能活不过十岁。

But here I am, 65 years later, defying the odds and living my best life. I've experienced firsthand how the company has transformed diabetes care and personally helped me beat those early odds in astounding ways,' said Payton. 'I'm forever grateful for the hope and support they've given me every day for nearly three decades.

但是，65年后，我依然在这里，战胜了逆境，过着最好的生活。佩顿说：“我亲身体验了这家公司如何改变了糖尿病护理，并在个人层面上以惊人的方式帮助我战胜了早期的困境。近三十年来，我每天都感激他们给予我的希望和支持。

Today, I'm a proud user of the MiniMed™ 780G system,** and my Time in Range.

今天，我是 MiniMed™ 780G 系统的自豪用户，**并且我的范围内时间。

has never been better. I'm finally sleeping through the night and worrying less about my diabetes — it's freeing.'

从未如此好过。我终于可以睡个整夜觉，也更少担心我的糖尿病了——这让我感到非常自由。

Based in

基于

Northridge, California

北岭，加利福尼亚州

, the Diabetes business is a passionate team of more than 8,000 employees dedicated to pushing the boundaries of innovation, developing breakthrough technologies that reduce burden, enhance quality of life, improve health outcomes, and redefine standards of care.

糖尿病业务部门是一个充满热情的团队，拥有8000多名员工，致力于突破创新界限，开发减轻负担、提高生活质量、改善健康结果并重新定义护理标准的突破性技术。

Medtronic is targeting completion of the planned separation within 18 months of the initial announcement, subject to customary conditions and legal requirements including consultations with works councils and other employee representative bodies.

美敦力预计在初次宣布后的18个月内完成计划中的分拆，但需符合惯例条件和法律要求，包括与工厂委员会及其他员工代表机构进行协商。